Position in BCLI
as of Jun 30, 2025
· filed Aug 11, 2025
Position Value
$31,050
-$3,881 QoQ
Shares Held
27,724
0.0% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $63,575,904,361 across 461 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in BCLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-06-30 | $31,050 | 27,724 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $34,931 | 27,724 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $178,060 | 78,441 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $347,446 | 1,510,640 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $513,617 | 1,510,640 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $784,555 | 1,400,993 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $384,293 | 1,423,310 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $284,662 | 1,423,310 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,932,018 | 1,423,310 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,714,158 | 1,428,533 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $2,342,793 | 1,428,533 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $6,311,326 | 1,427,902 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,941,008 | 1,427,902 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,774,892 | 1,421,099 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,722,288 | 1,430,572 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,726,982 | 1,432,419 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,368,737 | 1,412,826 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,095,630 | 1,330,452 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,866,747 | 1,295,088 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $20,335,181 | 1,201,843 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,201,609 | 1,356,076 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,643,501 | 1,216,272 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||